HF
EDVA

HRT Financial’s Endovia Health Sciences, Inc. EDVA Stock Holding History

HRT Financial’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Sell
14,172
-19,442
-58% -$20.1K ﹤0.01% 4004
2026
Q1 		$48K Buy
33,614
+27,542
+454% +$63.7K ﹤0.01% 3460
2025
Q4 		$16K Buy
6,072
+2,776
+84% +$16.6K ﹤0.01% 3013
2025
Q3 		$31K Buy
+3,296
New +$28.7K ﹤0.01% 2657
2025
Q1 		– Sell
-362
Closed -$9K – 3280
2024
Q4 		$9K Buy
+362
New +$12K ﹤0.01% 2294
2024
Q3 		– Sell
-93
Closed -$3K – 3040
2024
Q2 		$3K Buy
+93
New +$4.36K ﹤0.01% 2067

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HRT Financial's EDVA Position: Q2 2026 in Review

HRT Financial reduced its Endovia Health Sciences, Inc. (EDVA) stake by 58% in Q2 2026, selling an estimated $20.1K and leaving 14,172 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4004.

HRT Financial first reported a position in EDVA in Q2 2024 and has held it in 6 quarters since. The position peaked at $48K in Q1 2026. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • HRT Financial held 14,172 shares of Endovia Health Sciences, Inc. worth $8K as of Q2 2026.
  • HRT Financial sold 19,442 Endovia Health Sciences, Inc. shares in Q2 2026, an estimated $20.1K.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #4004 holding.
  • HRT Financial first reported a position in Endovia Health Sciences, Inc. in Q2 2024 and has held it in 6 quarters since.
  • HRT Financial's Endovia Health Sciences, Inc. position peaked at $48K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.